HEPATOLOGY101.Com

* Liver, Pancreas, Gall Bladder, Disease

* Viral Hepatitis, Hepatitis B, Research

* Find Hepatologists by State

* Hepatology News, Info, Resources

Filter= TIPSS

 

  Exact Time

 

 * Search on anything here:         Like us:      Follow us:   

 

 * Featured New Sites! =>

 

    

 

    

   

 

 

  

 

* Z101.COM *

 

** Useful Links **
  • Obituaries101
  • Accident Lawyers101
  • FIRE101
  •  FIRE101 MOBILE
  • POLICE101
  • Protect101
  • School Directions
  •  

  • ** Car Websites **
  •   Corvettes 101
  •   Mustangs 101
  • New Cars 101
  • Luxury Cars 101
  • Exotic Cars 101
  •  

  • ** Sports Websites **
  • Lacrosse 101
  • Volleyball 101
  • Cross Country 101
  • Rowing 101
  • Rugby 101
  • Softball 101
  • Water Polo 101
  • Karate 101
  • TKD 101
  •  

  • ** Medical Websites **
  • Internal Medicine 101
  • Sports Medicine 101
  • Nursing 101
  • OccupationalTherapy101
  • Orthopedics 101
  • Podiatry 101
  • Psychiatry 101
  •  

  • Diseases 101
  • Depression 101
  • Lyme Disease 101
  • OCD101
  •  

  • ** Lawyers Websites **
  • * Find Lawyers 101 *
  • Accident Lawyers 101
  • Defense Lawyers 101
  • Divorce Lawyers 101
  • DWI Lawyers 101
  • Malpractice Lawyers 101
  • Personal Injury Lawyers 101
  • Real Estate Lawyers 101
  • Tax Lawyers 101
  •  

     

     


     

     

    * Hepatology101 SEARCH *

    *Filter: "TIPSS"      

      

    Transjugular intrahepatic portosystemic shunt - Wikipedia
    Transjugular intrahepatic portosystemic shunt (TIPS or TIPSS) is an artificial channel within the liver that establishes communication between the inflow portal vein and the outflow hepatic vein. It is used to treat portal hypertension (which is often due to liver cirrhosis) which frequently leads to intestinal bleeding, life-threatening esophageal bleeding (esophageal varices) and the buildup ...

    Transjugular Intrahepatic Portosystemic Shunt: TIPS
    A TIPS relieves the high blood pressure in the portal vein (called portal hypertension) that often occurs in the setting of liver cirrhosis.

    Home page - Tipss.Public
    Customer-centric We draw on customer experience to design and develop our unique suite of products, ensuring that we continually exceed expectations.

    TIPS Procedure (Transjugular Intrahepatic Portosystemic Shunt)
    A TIPS procedure treats complications of severe liver disease that affect blood flow in your liver. TIPS stands for transjugular intrahepatic portosystemic shunt.

    Transjugular intrahepatic portosystemic shunts: Postprocedure care and ...
    Comprehensive guide on postprocedure care and complications of transjugular intrahepatic portosystemic shunts (TIPS).

    Transjugular Intrahepatic Portosystemic Shunt: Indications ...
    The transjugular intrahepatic portosystemic shunt (TIPS) procedure is effective in achieving portal decompression and in managing some of the major complications of portal hypertension. While many clinicians are familiar with the two most common ...

    Transjugular Intrahepatic Portosystemic Shunt (TIPSS) | CUH
    The TIPSS procedure inserts a shunt or tube into the liver through a vein in the neck; this is done using a needle. The shunt, or stent, is usually made of metallic mesh coated with strong fabric.

    Tipss — Empowering the Service Economy
    Tipss is a digital tipping platform with two apps: TipMe for individuals to receive tips cashlessly, and TipBiz for businesses to manage tip pooling automatically.

    Radiopaedia.org
    As a result of ever-increasing unsanctioned scraping by bots, we have instituted a challenge designed to keep them out, and make sure real users get the best experience possible.

    Access Your Account | The Thrift Savings Plan (TSP)
    Setting up My Account security features and keeping your contact information up to date is essential to protecting your account from fraud and making sure you receive TSP correspondence. With My Account access, you’ll be able to use convenient navigation to view and manage your investments, save time by submitting transaction requests online with your electronic signature, and more with ...

     

     



           * Hepatology101 LATEST NEWS *

                        *Filter: "TIPSS"

     

     

      
  •  NEW JOBS
  • Obituaries101
  • FIRE101
  • POLICE101
  • PROTECT101
  • School Directions
  • * POPULAR:  
  • Democrats101
  • Republicans101
  • NewCars101
  • LuxuryCars101
  • CarbonCapture101
  • *Sponsored: *Teleflora Flowers GREAT Deals!

     

    *Click a bouquet and send it today:
               

     

        ~~> 30% Off Discount Page - ALL FLOWERS! <~~

     

    *More Savings: 
    Get well: 20%    Sympathy & Funeral: 20%

     

             Birthday: $15    New Baby 15% off    Anniversary 15% off

    Common Hepatology Symptoms

    • Jaundice (Icterus) — Yellowing of the skin and sclera caused by elevated serum bilirubin levels due to impaired hepatic processing or biliary obstruction.
    • Ascites — Pathologic accumulation of fluid in the peritoneal cavity, commonly secondary to portal hypertension and advanced liver cirrhosis.
    • Hepatic Encephalopathy — Spectrum of neuropsychiatric abnormalities including confusion, asterixis, and altered consciousness resulting from neurotoxin accumulation.
    • Pruritus — Severe, generalized skin itching frequently associated with cholestatic liver diseases and systemic bile acid accumulation.
    • Right Upper Quadrant Abdominal Pain — Dull ache or sensation of fullness caused by stretching of Glisson's capsule surrounding an enlarged or inflamed liver.
    • Spider Angiomas and Palmar ErytHepa — Vascular cutaneous signs stemming from altered sex hormone metabolism and hyperdynamic circulation in chronic liver disease.
    • Dark Urine and Acholic Stools — Tea-colored urine from bilirubinuria paired with pale, clay-colored stools indicating impaired biliary drainage.

      

    * Useful Government Health Sites:                               

    Milestones in Hepatology History

    • Discovery of the Australia Antigen (1965) — Baruch Blumberg identified the surface antigen of Hepatitis B, paving the way for diagnostic screening and the first HBV vaccine.
    • First Successful Human Liver Transplant (1967) — Dr. Thomas Starzl performed the world's first successful human liver transplantation at the University of Colorado Health Sciences Center.
    • Identification of Hepatitis Delta Virus (1977) — Mario Rizzetto discovered the delta antigen, characterizing HDV as a defective subviral pathogen reliant on HBV co-infection.
    • Cloning and Identification of Hepatitis C (1989) — Michael Houghton, Harvey Alter, and Charles Rice isolated the non-A, non-B hepatitis virus, officially naming it Hepatitis C.
    • Introduction of MELD Score System (2002) — The Model for End-Stage Liver Disease was adopted in the United States to prioritize liver allocation based on 3-month mortality risk.
    • Approval of Direct-Acting Antivirals for HCV (2013) — The FDA approved Sofosbuvir, ushering in an era of highly effective, interferon-free oral curative regimens for chronic Hepatitis C.
    • Nomenclature Shift to MASLD and MASH (2023) — Global liver societies renamed NAFLD/NASH to better reflect underlying metabolic pathology and eliminate stigmatizing language.

    Current Hepatology Research

    • Bepirovirsen Functional Cure Trials — Evaluating antisense oligonucleotides to achieve a sustained loss of HBsAg and drug-free clinical response in patients living with chronic hepatitis B.
    • MASLD Diagnostics and Screening — Refining non-invasive biomarker panels and metabolic criteria to detect metabolic dysfunction-associated steatotic liver disease early in co-infected populations.
    • Hepatitis D Expanded Testing Protocols — Implementing reflexive antibody and RNA testing strategies to address global underdiagnosis of delta hepatitis co-infections.
    • Global Elimination Strategy Implementation — Tracking regional epidemiological data and public health interventions designed to accelerate viral hepatitis eradication goals.
    • RNA Interference (RNAi) Gene Silencing — Investigating small interfering RNA therapies to knock down viral transcripts and reduce antigen production in chronic liver infections.
    • MASH Fibrosis Biomarker Development — Validating novel serum panels and elastography metrics to monitor metabolic dysfunction-associated steatohepatitis regression without invasive biopsies.
    • In Vivo Gene Editing via Lipid Nanoparticles — Utilizing hepatic-targeted LNP delivery systems to correct monogenic metabolic liver disorders directly within host hepatocytes.
    • Gut Microbiome Alterations in Cirrhosis — Analyzing gut-liver axis dysbiosis to prevent bacterial translocation and manage portal hypertension complications in end-stage liver disease.

    HEPATOLOGY101.COM --- Hepatology Information, News, and Resources, Lots More

    Need to Find information on any subject? ASK THE HEPATOLOGY101 GURU!

     * Contact us:  support@z101.com
     
                                      

    Copyright 2010-2026  HEPATOLOGY101.COM